サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375898

光学式ゲノムマッピングの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2023年～2030年

Optical Genome Mapping Market Size, Share & Trends Analysis Report, By Product (Instruments, Software), By Application (Structural Variant Detection, Genome Assembly), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
光学式ゲノムマッピングの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月09日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

光ゲノムマッピング市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界の光ゲノムマッピング市場規模は、2030年には6億5,620万米ドルに達すると推定されています。

市場は、2023年から2030年にかけてCAGR 29.1％で成長すると予測されています。これは、様々な慢性疾患に対する効率的な治療法の研究の発展に起因しています。次世代シーケンシング（NGS）など他のゲノムシーケンス技術を補完する光ゲノムマッピング（OGM）の能力は、ゲノミクス研究における相乗効果を生み出しています。

研究者はオプティカル・マッピング・データをNGSデータと統合することで、ゲノムのより包括的なビューを得ることができ、これは臨床診断やがん研究において特に価値があります。2023年8月、Bionano Genomics社はCancer Genomics Consortium（CGC）2023年次総会に参加し、ポスター発表やBionano Genomics社からの科学的プラットフォームを含む、血液悪性腫瘍および固形腫瘍がん研究におけるOGMの有用性をカバーする幅広いセッションを行い、がんゲノミクス分野の著名な研究者によるパネルディスカッションも行いました。

技術の進歩はOGM産業の成長に重要な役割を果たしてきました。長年にわたり、光マッピングに使用される基礎技術は大幅に改善されてきました。蛍光顕微鏡のような高解像度イメージング技術はより洗練され、研究者は個々のDNA分子をこれまでにない精度で可視化し、解析できるようになっています。DNA標識法とデータ解析アルゴリズムの進歩により、OGMの精度と効率が向上し、ゲノム研究のための信頼できる強固なツールとなっています。2023年6月、Bionano Genomics社は、血液悪性腫瘍のゲノムデータを評価するためのソフトウェアを介して、ハイスループットOGM用のStratysシステムを導入しました。

さらに、光マッピング技術の利用しやすさも向上し、研究者や研究機関がより広く利用できるようになっています。いくつかの企業が商業的な光マッピング・プラットフォームを開発し、ゲノム研究のためのターンキー・ソリューションを提供しています。この商業化により、光マッピングはより利用しやすくなっただけでなく、さまざまな分野での採用が加速しています。

光ゲノムマッピング市場レポートハイライト

  • 市場は製品別に、装置、消耗品・試薬、ソフトウェア、サービス、その他に区分されます。2022年の売上高シェアは39.1%で、サービス分野が市場を独占しています。これは、機器の技術的進歩とサービスプロバイダーの増加によるものです。消耗品・試薬セグメントは予測期間中に有利なCAGRで成長すると予想されています。
  • 用途別では、構造変異検出分野が2022年に49.2%の収益シェアで市場を独占しました。一方、ゲノムアセンブリー分野は、遺伝子発現、ゲノムの多様性、複雑なデータシーケンスに関する調査の拡大により、予測期間で2番目に速いCAGRを示すと予測されています。
  • 最終用途別では、学術研究機関が59.1%の売上シェアで2022年の市場を独占しました。一方、病院・臨床検査機関セグメントは、新薬ターゲットや治療アプローチへの投資の増加により、CAGR 25.0%の好成長が見込まれています。
  • 地域別では、バイオテクノロジー分野への投資と資金調達の増加により、北米が2022年に43.4%の最大収益シェアで市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
  • 市場力学
  • 業界分析ツール

第4章 製品ビジネス分析

  • 光学ゲノムマッピング市場：製品変動分析
  • 楽器
    • 機器市場、2018～2030年
  • 消耗品および試薬
    • 消耗品および試薬市場、2018～2030年
  • ソフトウェア
    • ソフトウェア市場、2018～2030年
  • サービス
    • サービス市場、2018～2030年

第5章 アプリケーションビジネス分析

  • 光学ゲノムマッピング市場：アプリケーションの変動分析
  • 構造変異体の検出
  • ゲノムアセンブリ
  • 微生物株のタイピング
  • その他

第6章 エンドユーザービジネス分析

  • 光学ゲノムマッピング市場：エンドユーザーの変動分析
  • バイオテクノロジー企業と製薬会社
    • バイオテクノロジーおよび製薬会社の市場、2018年から2030年
  • 臨床検査室
    • 臨床検査市場、2018～2030年
  • 学術調査機関
    • 学術調査機関市場、2018年～2030年
  • その他
    • その他市場、2018-2030

第7章 地域ビジネス分析

  • 地域別の光学ゲノムマッピング市場シェア、2022年および2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • 世界のその他の地域

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市況分析、2022年
  • 企業プロファイル
    • Bionano Genomics
    • Nucleome Informatics Private Limited
    • Praxis Genomics, LLC
    • SourceBio International Limited（Source BioScience）
    • MedGenome
    • INRAE（French Plant Genomic Resources Center（CNRGV））
    • PerkinElmer（PerkinElmer Genomics）
    • Genohub Inc.
    • Hofkens Lab
    • Cerba
図表

List of Tables

  • Table 1 Global optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 2 Global optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 3 Global optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 4 Global optical genome mapping market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 8 North America optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 9 U.S. optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 12 Canada optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 15 Europe optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 19 UK optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 22 Germany optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 23 Germany optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 25 France optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 26 France optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 27 France optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 28 Italy optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 31 Spain optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 38 Japan optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 39 Japan optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 40 Japan optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 41 China optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 42 China optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 43 China optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 44 India optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 45 India optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 46 India optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 47 Australia optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 48 Australia optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 49 Australia optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 50 South Korea optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 51 South Korea optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 52 South Korea optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 53 Singapore optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 54 Singapore optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 55 Singapore optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 56 Rest of the World optical genome mapping market, by country, 2018 - 2030 (USD Million)
  • Table 57 Rest of the World optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 58 Rest of the World optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 59 Rest of the World optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 60 Brazil optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 61 Brazil optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 62 Brazil optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 63 Mexico optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 64 Mexico optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 65 Mexico optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 66 South Africa optical genome mapping market, by product, 2018 - 2030 (USD Million)
  • Table 67 South Africa optical genome mapping market, by application, 2018 - 2030 (USD Million)
  • Table 68 South Africa optical genome mapping market, by end-user, 2018 - 2030 (USD Million)
  • Table 69 Key companies undertaking acquisitions.
  • Table 70 Key companies launching new products/services
  • Table 71 Key companies undertaking collaborations and partnerships
  • Table 72 Key companies undertaking other initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Optical genome mapping market segmentation
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Value-chain-based sizing & forecasting
  • Fig. 10 QFD modeling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Commodity flow analysis
  • Fig. 13 Market snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Segment snapshot
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Market trends & outlook
  • Fig. 18 India disposable income, 2018 - 2020 (INR Million)
  • Fig. 19 Porter's five force analysis
  • Fig. 20 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
  • Fig. 21 Optical genome mapping market: product outlook key takeaways
  • Fig. 22 Optical genome mapping market: product movement analysis
  • Fig. 23 Instruments market, 2018 - 2030 (USD million)
  • Fig. 24 Consumables and reagents market, 2018 - 2030 (USD million)
  • Fig. 25 Software market, 2018 - 2030 (USD million)
  • Fig. 26 Services market, 2018 - 2030 (USD million)
  • Fig. 27 Optical genome mapping market: application outlook key takeaways
  • Fig. 28 Optical genome mapping market: application movement analysis
  • Fig. 29 Structural variant detection supplements market, 2018 - 2030 (USD million)
  • Fig. 30 Genome assembly supplements market, 2018 - 2030 (USD million)
  • Fig. 31 Microbial strain typing supplements market, 2018 - 2030 (USD million)
  • Fig. 32 Others supplements market, 2018 - 2030 (USD million)
  • Fig. 33 Optical genome mapping market: end-user outlook and key takeaways
  • Fig. 34 Optical genome mapping market: end-user movement analysis
  • Fig. 35 Biotechnology and pharmaceutical companies market, 2018 - 2030 (USD million)
  • Fig. 36 Clinical laboratories market, 2018 - 2030 (USD million)
  • Fig. 37 Academic research institutes market, 2018 - 2030 (USD million)
  • Fig. 38 Others market, 2018 - 2030 (USD million)
  • Fig. 39 Regional marketplace: key takeaways
  • Fig. 40 North America optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Europe optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 UK optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany optical Genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 France optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Spain optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Japan optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 China optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 India optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 South Korea optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Singapore optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Rest of the World optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Brazil optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Mexico optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 South Africa optical genome mapping market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Market participant categorization
  • Fig. 80 Strategic framework
目次
Product Code: GVR-4-68040-133-3

Optical Genome Mapping Market Growth & Trends:

The global optical genome mapping market size is estimated to reach USD 656.2 million by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 29.1% from 2023 to 2030. This can be attributed to developments in studying efficient treatments for a variety of chronic diseases. The ability of optical genome mapping (OGM) to complement other genomic sequencing technologies, such as next-generation sequencing (NGS), has created synergies in genomics research.

Researchers can integrate optical mapping data with NGS data to obtain a more comprehensive view of the genome, which is particularly valuable in clinical diagnostics and cancer research. In August 2023, Bionano Genomics participated in the Cancer Genomics Consortium (CGC) 2023 annual meeting with a wide range of sessions covering the utility of OGM for hematological malignancy and solid tumor cancer research, including poster presentations and scientific platform from Bionano Genomics, which also featured a panel discussion of esteemed researchers from across the cancer genomics field.

Technological advancements have played a significant role in the growth of the OGM industry. Over the years, there have been substantial improvements in the underlying technologies used in optical mapping. High-resolution imaging techniques, such as fluorescence microscopy, have become more sophisticated, enabling researchers to visualize and analyze individual DNA molecules with unprecedented precision. Advancements in DNA labeling methods and data analysis algorithms have enhanced the accuracy and efficiency of OGM, making it a reliable and robust tool for genomic research. In June 2023, Bionano Genomics introduced the Stratys system for high throughput OGM via software for evaluating genomic data for hematologic malignancies.

Moreover, the accessibility of optical mapping technology has also improved, making it more widely available to researchers and institutions. Several companies have developed commercial optical mapping platforms, offering turnkey solutions for genomics research. This commercialization has not only made optical mapping more accessible but has also accelerated its adoption across different sectors.

Optical Genome Mapping Market Report Highlights:

  • Based on product, the market is segmented into instruments, consumables and reagents, software, services, and others. The services segment dominated the market with a revenue share of 39.1% in 2022. This is attributed to the technological advancements in instruments and the increasing number of service providers. The consumables and reagents segment is expected to grow at a lucrative CAGR over the forecast period
  • Based on application, the structural variant detection segment dominated the market in 2022 with a revenue share of 49.2%. In contrast, the genome assembly segment is anticipated to exhibit the second fastest CAGR over the forecast period owing to the expanding research on gene expressions, genomic diversity, and complex data sequencing
  • Based on end-users, the academic research institutes segment dominated the market in 2022 with a revenue share of 59.1%. On the other hand, the hospitals and clinical laboratories segment is expected to grow at a lucrative CAGR of 25.0% owing to the increasing investment in new drug targets and therapeutic approaches
  • Based on region, North America dominated the market in 2022 with the largest revenue share of 43.4%, owing to the growing investments and funding in the biotechnology sector

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in genomic research
      • 3.2.1.2. Rising government funding and research initiatives
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Cost of equipment and consumables
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Optical Genome Mapping Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Consumables and Reagents
    • 4.3.1. Consumables and Reagents Market, 2018 - 2030 (USD Million)
  • 4.4. Software
    • 4.4.1. Software Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Optical Genome Mapping Market: Application Movement Analysis
  • 5.2. Structural Variant Detection
    • 5.2.1. Structural Variant Detection Market, 2018 - 2030 (USD Million)
  • 5.3. Genome Assembly
    • 5.3.1. Genome Assembly Market, 2018 - 2030 (USD Million)
  • 5.4. Microbial Strain Typing
    • 5.4.1. Microbial Strain Typing Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-user Business Analysis

  • 6.1. Optical Genome Mapping Market: End-user Movement Analysis
  • 6.2. Biotechnology and Pharmaceutical Companies
    • 6.2.1. Biotechnology and Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Clinical Laboratories
    • 6.3.1. Clinical Laboratories Market, 2018 - 2030 (USD Million)
  • 6.4. Academic research institutes
    • 6.4.1. Academic research institutes Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Optical Genome Mapping Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Optical Genome Mapping Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Optical Genome Mapping Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.6. Singapore
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Singapore Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Optical Genome Mapping Market, 2018 - 2030 (USD Million)
  • 7.5. Rest of the World
    • 7.5.1. Rest of the World Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico Optical Genome Mapping Market, 2018 - 2030 (USD Million)
    • 7.5.4. South Africa
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. South Africa Optical Genome Mapping Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2022
  • 8.4. Company Profiles
    • 8.4.1. Bionano Genomics
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Nucleome Informatics Private Limited
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Praxis Genomics, LLC
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. SourceBio International Limited (Source BioScience)
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. MedGenome
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. INRAE (French Plant Genomic Resources Center (CNRGV))
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. PerkinElmer (PerkinElmer Genomics)
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Genohub Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Hofkens Lab
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Cerba
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives